SAN FRANCISCO - Barclays Global Investors has launched a biotechnology exchange-traded fund.
The iShares Nasdaq Biotechnology Index Fund will track the Nasdaq biotechnology index. The index includes companies engaged in biomedical research, and in developing new treatments and cures for human diseases.
The fund will be managed by Barclays Global Fund Advisors, a subsidiary of Barclays Global Investors. The launch was announced last Thursday.